ASTRANA HEALTH INC (ASTH) Stock Price & Overview
NASDAQ:ASTH • US03763A2078
Current stock price
The current stock price of ASTH is 26.105 USD. Today ASTH is up by 4.21%. In the past month the price decreased by -0.08%. In the past year, price decreased by -16.69%.
ASTH Key Statistics
- Market Cap
- 1.291B
- P/E
- 56.75
- Fwd P/E
- 20.69
- EPS (TTM)
- 0.46
- Dividend Yield
- N/A
ASTH Stock Performance
ASTH Stock Chart
ASTH Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to ASTH. When comparing the yearly performance of all stocks, ASTH is a bad performer in the overall market: 78.74% of all stocks are doing better.
ASTH Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to ASTH. ASTH has a bad profitability rating. Also its financial health evaluation is rather negative.
ASTH Earnings
On March 2, 2026 ASTH reported an EPS of 0.12 and a revenue of 950.53M. The company beat EPS expectations (10.99% surprise) and beat revenue expectations (0.15% surprise).
ASTH Forecast & Estimates
17 analysts have analysed ASTH and the average price target is 36.72 USD. This implies a price increase of 40.66% is expected in the next year compared to the current price of 26.105.
For the next year, analysts expect an EPS growth of 174.35% and a revenue growth 25.65% for ASTH
ASTH Groups
Sector & Classification
ASTH Financial Highlights
Over the last trailing twelve months ASTH reported a non-GAAP Earnings per Share(EPS) of 0.46. The EPS decreased by -48.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.71% | ||
| ROA | 1.01% | ||
| ROE | 2.89% | ||
| Debt/Equity | 1.27 |
ASTH Ownership
ASTH Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 10.15 | 93.495B | ||
| CI | THE CIGNA GROUP | 8.8 | 71.194B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 104.8 | 27.674B | ||
| LH | LABCORP HOLDINGS INC | 15.03 | 22.555B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.49 | 21.757B | ||
| GH | GUARDANT HEALTH INC | N/A | 12.308B | ||
| DVA | DAVITA INC | 10.49 | 9.725B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 31.52 | 8.291B | ||
| CHE | CHEMED CORP | 15.82 | 5.241B | ||
| AGL | AGILON HEALTH INC | N/A | 4.456B | ||
| HIMS | HIMS & HERS HEALTH INC | 36.72 | 4.363B | ||
| OPCH | OPTION CARE HEALTH INC | 14.57 | 4.298B | ||
| RDNT | RADNET INC | 69.11 | 4.252B |
Related stock screener links
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ASTH
Company Profile
Astrana Health, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. The company is headquartered in Alhambra, California and currently employs 3,000 full-time employees. The firm provides care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The firm's segments include Care Partners, Care Delivery, and Care Enablement. Its Care Partners segment is focused on building and managing provider networks by partnering with, empowering, and investing in provider partners aligned on a shared vision for coordinated care delivery. Its Care Delivery organization includes primary care, multi-specialty care, and ancillary care services. Its Care Enablement segment represents a comprehensive platform that integrates clinical, operational, financial, and administrative information. The company supports more than 20,000 providers.
Company Info
IPO: 1999-04-09
ASTRANA HEALTH INC
1668 S. Garfield Avenue, 2Nd Floor
Alhambra CALIFORNIA US
Employees: 3000
Phone: 16262820288
ASTRANA HEALTH INC / ASTH FAQ
Can you describe the business of ASTRANA HEALTH INC?
Astrana Health, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. The company is headquartered in Alhambra, California and currently employs 3,000 full-time employees. The firm provides care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The firm's segments include Care Partners, Care Delivery, and Care Enablement. Its Care Partners segment is focused on building and managing provider networks by partnering with, empowering, and investing in provider partners aligned on a shared vision for coordinated care delivery. Its Care Delivery organization includes primary care, multi-specialty care, and ancillary care services. Its Care Enablement segment represents a comprehensive platform that integrates clinical, operational, financial, and administrative information. The company supports more than 20,000 providers.
What is the stock price of ASTRANA HEALTH INC today?
The current stock price of ASTH is 26.105 USD. The price increased by 4.21% in the last trading session.
What is the dividend status of ASTRANA HEALTH INC?
ASTH does not pay a dividend.
How is the ChartMill rating for ASTRANA HEALTH INC?
ASTH has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Where is ASTRANA HEALTH INC (ASTH) stock traded?
ASTH stock is listed on the Nasdaq exchange.
How is the market expecting ASTH stock to perform?
17 analysts have analysed ASTH and the average price target is 36.72 USD. This implies a price increase of 40.66% is expected in the next year compared to the current price of 26.105.
Should I buy ASTH stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ASTH.